Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases
Frank Hilberg(Boehringer Ingelheim (Austria)), Norbert Kraut(Boehringer Ingelheim (Austria))
Cited by 105
Related Papers
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
|Cancer Research|2008|1.1k